1003-28-7Relevant articles and documents
PALLADIUM-PROMOTED CYCLIZATION REACTIONS OF AMINOALKENES
Pugin, Benoit,Venanzi, Luigi M.
, p. 125 - 133 (1981)
The trifluoromethanesulphonate salts of the aminoalkenes CH2=CH(CH2)3NH2, its 2-methyl, 2,2-dimethyl and N-iso-propyl-derivatives, and CH2=CH(CH2)4NH2 cyclize in the presence of and a nitrogen base to produce the corresponding C- or N-substituted 2-methylpyrrolidines and 2-methylpiperidine, E-CH3CH=CH(CH2)3NH2 produces 2-ethylpyrrolidine and a small amount of 2-methylpiperidine.The regio-selectivity of these reactions differs from that observed for the cyclization of the same substrates promoted by 2-: (1) the palladium reaction with 2-methylpent-4-enylamine produces ca. a 4 : 6 ratio of cis- and trans-2,4-dimethylpyrrolidine while with platinum the converse is true; (2) there is a more marked tendency for attack of the amine at the more substituted alkene carbon atom in the palladium than in the platinum reactions.
Organolanthanide-catalyzed intramolecular hydroamination/ cyclization of amines tethered to 1,2-disubstituted alkenes
Ryu, Jae-Sang,Marks, Tobin J.,McDonald, Frank E.
, p. 3091 - 3094 (2001)
(equation presented) This contribution reports the organolanthanide-catalyzed intramolecular hydroamination/cyclization of amines tethered to 1,2-disubstituted alkenes to afford the corresponding mono-and disubstituted pyrrolidines and piperidines by usin
-
Warner,Moe
, p. 1064 (1952)
-
AMMONIUM SALT, ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY USING THEM
-
Paragraph 0061, (2017/12/01)
PROBLEM TO BE SOLVED: To provide: ammonium salt with low viscosity; an electrolyte for a lithium secondary battery; and the lithium secondary battery. SOLUTION: This invention relates to an ammonium salt expressed by the following chemical formula (1). SELECTED DRAWING: None COPYRIGHT: (C)2018,JPO&INPIT
GLYT1 TRANSPORTER INHIBITORS
-
Page/Page column 42, (2010/02/12)
The invention provides a compound of formula (I): or a salt, solvate or a physiologically functional derivative thereof, wherein R1 to R10 are as defined in the specification and uses of such compounds. The compounds inhibit GlyT1 transporters and are useful in the treatment of certain neurological and neuropsychiatric disorders, including schizophrenia.